共 50 条
- [1] ONTARGET study of telmisartan, ramipril, or both in high-risk patients[J]. CURRENT HYPERTENSION REPORTS, 2008, 10 (05) : 345 - 348Ram, C. Venkata S.
- [2] ONTARGET study of telmisartan, ramipril, or both in high-risk patients[J]. Current Hypertension Reports, 2008, 10 : 345 - 348C. Venkata S. Ram
- [3] Telmisartan, Ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial[J]. KARDIOLOGIYA, 2008, 48 (05) : 72 - 72Lyakishev, A. A.
- [4] ONTARGET: Use of ramipril, telmisartan, or both in patients with high cardiovascular risks[J]. Current Diabetes Reports, 2009, 9 (3) : 185 - 187HoWon LeeAmgad N. MakaryusSamy I. McFarlane
- [5] Review of ONTARGET: Treating Patients at High Risk for Vascular Events with Telmisartan, Ramipril, or Both[J]. POSTGRADUATE MEDICINE, 2009, 121 (02) : 202 - 204Guthrie, Robert M.
- [6] Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data[J]. CHINESE MEDICAL JOURNAL, 2011, 124 (12) : 1763 - 1768Yu Li-tianZhu JunTan Hui-qiongWang Guo-ganTeo, Koon K.Liu Li-sheng
- [7] Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials[J]. CIRCULATION, 2010, 121 (12) : 1439 - U114Boehm, MichaelBaumhaekel, MagnusTeo, KoonSleight, PeterProbstfield, JeffreyGao, PeggyMann, Johannes F.Diaz, RafaelDagenais, Gilles R.Jennings, Garry L. R.Liu, LishengJansky, PetrYusuf, Salim
- [8] A comparison of efficacy of telmisartan and ramipril alone or in combination in reduction of cardiovascular events in high-risk patients - results from the ONTARGET study[J]. ARTERIAL HYPERTENSION, 2008, 12 (02): : 140 - 147Szczepaniak-Chichel, Ludwina
- [9] Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant Subjects With Cardiovascular Disease (ONTARGET/TRANSCEND) Trials Editorial Comment[J]. JOURNAL OF UROLOGY, 2010, 184 (04): : 1454 - 1455Seftel, Allen
- [10] Telmisartan, ramipril, or both in patients at high risk for vascular events[J]. CURRENT HYPERTENSION REPORTS, 2008, 10 (05) : 343 - 344Vidt, Donald G.